Pernix Therapeutics Holdings (PTX US)

Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis; statin-induced ubiquinone deficiency; deficiencies in active cultures due to diet and antibiotics; and upper respiratory conditions.